TY  - GEN
AU  - Tantai,Narisa
AU  - Chaikledkaew,Usa
AU  - Tanwandee,Tawesak
AU  - Werayingyong,Pitsaphun
AU  - Teerawattananon,Yot
TI  - A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
SN  - 1472-6963
PY  - 2015///0114
KW  - Adenine
KW  - analogs & derivatives
KW  - Adult
KW  - Antiviral Agents
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Drugs, Essential
KW  - Female
KW  - Health Services Research
KW  - Hepatitis B e Antigens
KW  - Hepatitis B, Chronic
KW  - drug therapy
KW  - Humans
KW  - Lamivudine
KW  - Male
KW  - Markov Chains
KW  - Models, Economic
KW  - Organophosphonates
KW  - Quality-Adjusted Life Years
KW  - Tenofovir
KW  - Thailand
KW  - epidemiology
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1472-6963-14-170
ER  -